June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Hagfish slime protein membranes as in vitro models of Bruch’s membrane in the subretinal tissue
Author Affiliations & Notes
  • Emilee Rickabaugh
    Biological Engineering, Utah State University, Logan, Utah, United States
  • Dillon Weatherston
    Biological Engineering, Utah State University, Logan, Utah, United States
  • Thomas Harris
    Biology, Utah State University, Logan, Utah, United States
  • Justin Jones
    Biology, Utah State University, Logan, Utah, United States
  • Elizabeth Vargis
    Biological Engineering, Utah State University, Logan, Utah, United States
  • Footnotes
    Commercial Relationships   Emilee Rickabaugh None; Dillon Weatherston None; Thomas Harris None; Justin Jones None; Elizabeth Vargis None
  • Footnotes
    Support  NIH Grant R15EY028732
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3738 – F0344. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emilee Rickabaugh, Dillon Weatherston, Thomas Harris, Justin Jones, Elizabeth Vargis; Hagfish slime protein membranes as in vitro models of Bruch’s membrane in the subretinal tissue. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3738 – F0344.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Bruch’s membrane resides in the subretinal tissue and helps to regulate the flow of nutrients and waste between the retinal pigmented epithelial (RPE) and vascular cell layers of the eye. Bruch’s membrane plays a key role in the development of subretinal diseases such as Age-Related Macular Degeneration. Age-Related Macular Degeneration, or AMD, is the degradation of the RPE cell layer, leading to progressive vision loss. Bruch’s membrane plays an active role in the development of AMD. The thickness, brittleness, and permeability of Bruch’s membrane all have a significant impact on the degradation of the RPE cell layer. As the interactions between Bruch’s membrane, the RPE layer, and the vascular layer play a pivotal role in AMD, modeling these layers is a key step in researching potential therapies for AMD and other retinal diseases.
An accurate model of Bruch’s membrane must be proteinaceous, semi-permeable, and nonporous with similar mechanical properties to in vivo Bruch’s membrane while also being able to support both RPE and vascular cell cultures. Many current models of the subretinal tissue utilize inferior models of Bruch’s membrane called Transwells, which are porous, nonpermeable, plastic membranes that are much thicker than a healthy Bruch’s membrane.

Methods : To create a more accurate model, artificial membranes were synthesized using solubilized hagfish slime proteins. The characteristics of the hagfish membranes were evaluated using mechanical stress testing, permeability assays, and brightfield microscopy. The capacity of the membranes to support ARPE-19 and Human Retinal Microvascular Endothelial Cell cultures was determined using cell staining with brightfield microscopy, fluorescent microscopy, immunocytochemical imaging, and enzyme-linked immunosorbent assays.

Results : The tests demonstrate the potential of these hagfish protein membranes to accurately replicate Bruch’s membrane in an in vitro model of the subretinal tissue. When compared to existing models of the subretinal tissue, the hagfish membranes demonstrate more mimetic geometric properties, mechanical properties, and permeability characteristics to those of a natural Bruch’s membrane, as well as the ability to support relevant cell cultures.

Conclusions : The verification of this model will create an opportunity for more comprehensive and accelerated initial testing for potential retinal disease therapies.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×